Alembic Pharma Moves Gujarat HC Against Rs 42 Crore Power Utility Invoices

Written By :  Susmita Roy
Published On 2025-12-20 11:07 GMT   |   Update On 2025-12-20 11:07 GMT
Advertisement

New Delhi: Alembic Pharmaceuticals has approached the Gujarat High Court challenging supplementary invoices amounting to over Rs 42 crore issued by Madhya Gujarat Vij Company Limited (MGVCL) in connection with the installation of a rooftop solar photovoltaic (PV) system.

The company has been served with supplementary invoices from Madhya Gujarat Vij Company Limited (MGVCL), Gujarat, related to the installation of a rooftop solar PV system, for which the company has filed writ petition(s) with the Hon’ble High Court of Gujarat, Ahmedabad, seeking to quash and set aside the matter.

Advertisement

In its recent filing, the company stated that it has filed writ petition(s) before the High Court of Gujarat at Ahmedabad seeking to quash and set aside the impugned supplementary invoices for a cumulative amount of Rs. 42,16,82,065/- issued by Madhya Gujarat Vij Company Limited (MGVCL) regarding the rooftop solar PV system.

The company stated that the litigation is presently pending before the Gujarat High Court, with the State of Gujarat and others named as respondents in the matter. Alembic Pharma clarified that the financial impact, if any, would depend on the final outcome of the proceedings and that, as of now, there is no immediate financial liability arising from the dispute.

Total quantum of claim for said litigation amounts to Rs. 42,16,82,065/- only. The amount is disputed and the final impact in monetary terms will be known only when the matter is finally disposed of, the company stated.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News